W. Ray Kim

Active 1996–2025

Also published as
W. RAY KIM
109
Papers
22,036
Citations
73
h-index
103
i10-index

Citations

Citations per year for W. Ray Kim1939: 1 citations1967: 1 citations1994: 1 citations1997: 1 citations1998: 1 citations1999: 9 citations2000: 10 citations2001: 24 citations2002: 13 citations2003: 23 citations2004: 26 citations2005: 26 citations2006: 33 citations2007: 39 citations2008: 56 citations2009: 66 citations2010: 103 citations2011: 99 citations2012: 109 citations2013: 127 citations2014: 109 citations2015: 158 citations2016: 164 citations2017: 163 citations2018: 206 citations2019: 699 citations2020: 720 citations2021: 696 citations2022: 487 citations2023: 477 citations2024: 802 citations2025: 359 citations2026: 16 citations1940–1966: no citations, so these years are not shown1968–1993: no citations, so these years are not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,499 citing papers, 29.3% of this breakdownChina: 707 citing papers, 8.3% of this breakdownUnited Kingdom: 528 citing papers, 6.2% of this breakdownCanada: 432 citing papers, 5.1% of this breakdownItaly: 425 citing papers, 5% of this breakdownSpain: 315 citing papers, 3.7% of this breakdownFrance: 312 citing papers, 3.6% of this breakdownGermany: 305 citing papers, 3.6% of this breakdownSouth Korea: 219 citing papers, 2.6% of this breakdownJapan: 185 citing papers, 2.2% of this breakdownAustralia: 183 citing papers, 2.1% of this breakdownNetherlands: 178 citing papers, 2.1% of this breakdown
0%29.3%Other 26.2%

Fields

  • Medicine91.9%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Immunology and Microbiology0.8%
  • Agricultural and Biological Sciences0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Health Professions0.5%
  • Other1.9%

Topics

  • Liver Disease Diagnosis and Treatment14.4%
  • Liver Disease and Transplantation13%
  • Organ Transplantation Techniques and Outcomes6.7%
  • Hepatitis C virus research4.3%
  • Hepatitis B Virus Studies3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis3.7%
  • Other54%

Coauthors

All papers

Open in search
  1. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era

    Authors: , , , , , , , , - Gastroenterology 2021 cited by 589

  2. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

    Authors: , , , , , , , - Hepatology 2021 cited by 799

  3. OPTN/SRTR 2021 Annual Data Report: Liver

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2023 cited by 327

  4. Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

    Authors: , , , , , , , - New England Journal of Medicine 2008 cited by 1,485

  5. Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance

    Authors: , , , , , , - Hepatology 2024 cited by 154

  6. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

    Authors: , , , , , , , , , , , , , , , , , - Gut 2015 cited by 864

  7. OPTN/SRTR 2020 Annual Data Report: Liver

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2022 cited by 375

  8. Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

    Authors: , , , , , , , , , , , - Gastroenterology 2006 cited by 777

  9. OPTN/SRTR 2022 Annual Data Report: Liver

    Authors: , , , , , , , , , , - American Journal of Transplantation 2024 cited by 200

  10. The steatosis‐associated fibrosis estimator (SAFE) score: A tool to detect low‐risk NAFLD in primary care

    Authors: , , , , , , , , - Hepatology 2022 cited by 105

  11. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†

    Authors: , , , - Hepatology 2008 cited by 868

  12. Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers

    Authors: , , , , , , , , , , , , , , , - Gastroenterology 2012 cited by 591

  13. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation

    Authors: , , , , , , - Transplantation 2018 cited by 182

  14. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2015 cited by 291

  15. Diagnosis and Management of Primary Biliary Cholangitis

    Authors: , , , , , , - The American Journal of Gastroenterology 2018 cited by 209

  16. Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 61

  17. Nonobese Fatty Liver Disease

    Authors: , - Clinical Gastroenterology and Hepatology 2016 cited by 346

  18. MELD accurately predicts mortality in patients with alcoholic hepatitis†

    Authors: , , , , , , , , - Hepatology 2005 cited by 530

  19. OPTN/SRTR 2018 Annual Data Report: Liver

    Authors: , , , , , , , , , , , - American Journal of Transplantation 2020 cited by 389

  20. Increased Prevalence and Mortality in Undiagnosed Celiac Disease

    Authors: , , , , , , , , , , , , - Gastroenterology 2009 cited by 769

  21. OPTN/SRTR 2019 Annual Data Report: Liver

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2021 cited by 308

  22. Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes

    Authors: , , , , , , , - Hepatology 2014 cited by 180

  23. Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cynthia Levy, Anna Lok, Michael R. Lucey, V LUKETIC, Richard Manch, W. van der Mark, Marlyn J. Mayo, Edward Mena, Apurva A. Modi, Gautham P. Reddy, K. Rajender Reddy, Fedja A. Rochling, Sergio Rojter, Raymond A. Rubin, Mark Russo, Mitchell Shiffman, Marina G. Silveira, Carmen Stanca, Paul J. Thuluvath, Elizabeth C. Verna, Laurence Weiss, Cynthia Levy - Digestive Diseases and Sciences 2022 cited by 70

  24. Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

    Authors: , , - Clinics in Liver Disease 2017 cited by 241